Changes in Fatigue Over 2 Years Are Associated With Activity of Inflammatory Bowel Disease and Psychological Factors

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 9, 2013, Pages 1140-1146

  Graff, Lesley A ^a   Clara, Ian ^a   Walker, John R ^a   Lix, Lisa ^a   Carr, Rachel ^b   Miller, Norine ^a   Rogala, Linda ^a   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Fatigue; Inflammatory Bowel Disease; Longitudinal; Psychological Functioning

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; DISTRESS SYNDROME; ENTERITIS; FATIGUE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL FATIGUE INVENTORY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; SLEEP QUALITY;

C-REACTIVE PROTEIN; CD; CROHN'S DISEASE; CRP; FATIGUE; IBD; ICC; INFLAMMATORY BOWEL DISEASE; INTRACLASS CORRELATION; LONGITUDINAL; MANITOBA INFLAMMATORY BOWEL DISEASE INDEX; MIBDI; PSYCHOLOGICAL FUNCTIONING; UC; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FATIGUE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LONGITUDINAL STUDIES; MALE; MANITOBA; MIDDLE AGED; PSYCHOTHERAPY; YOUNG ADULT;

EID: 84882815168     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.03.031     Document Type: Article

References (59)

1. Graff L.A., Walker J.R., Russell A.S., et al. Fatigue and quality of sleep in patients with immune mediated inflammatory disease. J Rheumatol 2011, 38(Suppl 88):36-42.
2. Shen J., Barbera J., Shapiro C.M. Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med Rev 2006, 10:63-76.
3. Rupp I., Boshuizen H.C., Jacobi C.E., et al. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 2004, 51:578-585.
4. Havlikova E., Rosenberger J., Nagyova I., et al. Impact of fatigue on quality of life in patients with Parkinson's disease. Eur J Neurol 2008, 15:475-480.
5. Jelsness-Jørgensen L.P., Bernklev T., Henriksen M., et al. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:106-114.
6. Drossman D.A., Patrick D.L., Mitchell C.M., et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989, 34:1379-1386.
7. Levenstein S., Li Z., Almer S., et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:1822-1830.
8. Singh S., Blanchard A., Walker J.R., et al. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2011, 9:769-775.
9. van Langenberg D.R., Gibson P.R. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 2010, 32:131-143.
10. Graff LA, Vincent N, Walker JR, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 201;17:1882-1889.
11. Romberg-Camps M.J., Bol Y., Dagnelie P.C., et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010, 16:2137-2147.
12. Römkens T.E., van Vugt-van Pinxteren M.W., Nagengast F.M., et al. High prevalence of fatigue in inflammatory bowel disease: a case control study. J Crohns Colitis 2011, 5:332-337.
13. Simrén M., Svedlund J., Posserud I., et al. Predictors of subjective fatigue in chronic gastrointestinal disease. Aliment Pharmacol Ther 2008, 28:638-647.
14. van Hoogmoed D., Fransen J., Bleijenberg G., et al. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 2010, 49:1294-1302.
15. Bernstein C.N., Blanchard J.F., Rawsthorne P., et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999, 149:916-924.
16. Graff L.A., Walker J.R., Lix L., et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006, 4:1491-1501.
17. Longobardi T., Walker J.R., Graff L.A., et al. Health service utilization in IBD: comparison of self-report and administrative data. BMC Health Serv Res 2011, 11:137. http://www.biomedcentral.com/1472-6963/11/137.
18. Clara I., Lix L.M., Walker J.R., et al. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol 2009, 104:1754-1763.
19. Harvey R.F., Bradshaw J.M. A simple index of Crohn's disease activity. Lancet 1980, 1:514.
20. Powell-Tuck J., Bown R.L., Lennard-Jones J.E. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978, 13:833-837.
21. Lix L.M., Graff L.A., Walker J.R., et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1575-1584.
22. Smets E.M., Garssen B., Bonke B., et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39:315-325.
23. Minderhoud I.M., Oldenburg B., van Dam P.S., et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003, 98:1088-1093.
24. Bager P., Befrits R., Wikman O., et al. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther 2012, 35:133-141.
25. Buysse D.J., Reynolds C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
26. Derogatis L.R., Savitz K.C. The SCL-90-R and brief symptom inventory (BSI) in primary care. Handbook of psychological assessment in primary care settings 2000, Lawrence Erlbaum Associates, New Jersey. M. Maruish (Ed.).
27. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24:385-396.
28. Massé R., Poulin C., Dassa C., et al. [Elaboration and validation of a tool to measure psychological well-being: WBMMS]. Can J Public Health 1998, 89:352-357.
29. Cudek R. Mixed-effects models in the study of individual differences with repeated measures data. Multivariate Behav Res 1996, 31:371-403.
30. Hedeker D., Gibbons R.D. Longitudinal data analysis 2006, Wiley, Hoboken, NJ.
31. SAS/Stat user's guide, version 9.2 2008, SAS Institute, Inc, SAS Institute, Inc, Cary, NC.
32. Schwarz R., Krauss O., Hinz A. Fatigue in the general population. Onkologie 2003, 26:140-144.
33. Banovic I., Gilibert D., Cosnes J. Crohn's disease and fatigue: constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life. Psychol Health Med 2010, 15:394-405.
34. Banovic I., Gilibert D., Jebrane A., et al. Diagnostic profiles determined by the C.A.R.T. procedure: IBD patients and fatigue. J Health Psychol 2012, 17:500-508.
35. Arnett S.V., Clark I.A. Inflammatory fatigue and sickness behaviour - lessons for the diagnosis and management of chronic fatigue syndrome. J Affect Disord 2012, 141:130-142.
36. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007, 21:374-383.
37. Lotrich F.E., El-Gabalawy H., Guenther L.C., et al. The role of inflammation in the pathophysiology of depression: different treatments and their effects. J Rheumatol Suppl 2011, 38(Suppl 88):48-54.
38. Bonaz B.L., Bernstein C.N. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013, 144:36-49.
39. Casellas F., Barreiro de Acosta M., Iglesias M., et al. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2012, 24:762-769.
40. Walker J.R., Ediger J.P., Graff L.A., et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008, 103:1989-1997.
41. Mancuso C.A., Rincon M., Sayles W., et al. Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006, 33:1496-1502.
42. Repping-Wuts H., Fransen J., van Achterberg T., et al. Persistent fatigue in patients with rheumatoid arthritis. J Clin Nurs 2007, 16:377-383.
43. Treharne G.J., Lyons A.C., Hale E.D., et al. Predictors of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med 2008, 13:494-504.
44. Husted J.A., Tom B.D., Farewell V.T., et al. Longitudinal analysis of fatigue in psoriatic arthritis. J Rheumatol 2010, 37:1878-1884.
45. Dagfinrud H., Vollestad N.K., Loge J.H., et al. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 2005, 53:5-11.
46. Meyers C.A., Albitar M., Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005, 104:788-793.
47. Goldenberg B, Graff CI, et al. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol. In press.
48. Gasche C., Lomer M.C., Cavill I., et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004, 53:1190-1197.
49. Evers A.W., Kraaimaat F.W., van Riel P.L., et al. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 2002, 100:141-153.
50. Mikocka-Walus A.A., Turnbull D., Holtmann G., et al. An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation. Inflamm Bowel Dis 2012, 18:1573-1581.
51. García-Vega E., Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther 2004, 42:367-383.
52. Diaz Sibaja M.A., Comeche Moreno M.I., Mas Hesse B. [Protocolized cognitive-behavioural group therapy for inflammatory bowel disease]. Rev Esp Enferm Dig 2007, 99:593-598.
53. Mizrahi M.C., Reicher-Atir R., Levy S., et al. Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease. Psychol Health 2012, 27:1-17.
54. Vogelaar L., van't Spikjer A., Vogelaar T. Solution-focussed therapy: a promising new tool in the management of fatigue in Crohn's disease patients. Psychological interventions for the management of fatigue in Crohn's disease. J Crohns Colitis 2011, 5:585-591.
55. Vincent N., Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep 2009, 32:807-815.
56. Lange G., Cook D.B., Natelson B.H. Rehabilitation and treatment of fatigue. Fatigue as a window to the brain 2005, 301-316. Massachusetts Institute of Technology, Cambridge, MA. J. DeLuca (Ed.).
57. Louden C.P., Corroll V., Butcher J., et al. The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol 1999, 94:697-703.
58. Schoepfer A.M., Beglinger C., Straumann A., et al. Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010, 105:162-169.
59. Abraham B.P., Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am 2012, 41:483-495.